The global monoclonal antibody (mAb) market is witnessing significant growth, driven by the increasing demand for targeted therapies in the treatment of cancer, autoimmune diseases, and infectious diseases. With advancements in biotechnology and immunotherapy, monoclonal antibodies are revolutionizing modern medicine by offering high specificity, minimal side effects, and enhanced...
English
العربية
Français
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt